KAS
MBIO icon

Kestra Advisory Services’s Mustang Bio MBIO Stock Holding History

Kestra Advisory Services’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
196,991
+20,949
+12% +$14.9K ﹤0.01% 3147
2026
Q1 		$128K Buy
176,042
+65,000
+59% +$61.2K ﹤0.01% 3002
2025
Q4 		$109K Buy
111,042
+44,934
+68% +$59.3K ﹤0.01% 3358
2025
Q3 		$100K Buy
+66,108
New +$118K ﹤0.01% 2819

Other funds holding MBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Kestra Advisory Services's MBIO Position: Q2 2026 in Review

Kestra Advisory Services increased its Mustang Bio (MBIO) stake by 12% in Q2 2026, buying an estimated $14.9K and bringing the position to 196,991 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Kestra Advisory Services first reported a position in MBIO in Q3 2025 and has held it in 4 quarters since. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • Kestra Advisory Services held 196,991 shares of Mustang Bio worth $138K as of Q2 2026.
  • Kestra Advisory Services bought 20,949 Mustang Bio shares in Q2 2026, an estimated $14.9K.
  • Mustang Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3147 holding.
  • Kestra Advisory Services first reported a position in Mustang Bio in Q3 2025 and has held it in 4 quarters since.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.